Polpharma Biologics CEO Discusses Natalizumab Milestone

Q&A With Michael Soldan After CHMP Positive Opinion On Tysabri Biosimilar

 
• By David Wallace
  
Q&A written on wooden blocks, cubes
Polpharma Biologics CEO Michael Soldan discusses natalizumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products